Skip to main content

China Focus: Over 700 mln COVID-19 vaccine doses administered across China

Abstract : More than 704.8 million doses of COVID-19 vaccines had been administered across China as of Wednesday, the National Health Commission (NHC) said Thursday.

BEIJING, June 3 (Xinhua) — More than 704.8 million doses of COVID-19 vaccines had been administered across China as of Wednesday, the National Health Commission (NHC) said Thursday.

The number of doses administered has continued to rise at an ever-faster rate since China hit the landmark figure of 100 million on March 27.

China took just 25 days to hit the next milestone of administering 200 million doses nationwide. It only took five days to increase vaccine distribution from 600 million doses to 700 million.

A total of 20 vaccines have entered clinical trials in China since last year, according to Zheng Zhongwei, an official with the NHC. “China has been taking the lead in terms of the number of vaccines that are being developed.”

While quickening domestic vaccination and vaccine research and development, China has honored its solemn commitment to making COVID-19 vaccines a “global public good,” despite its own huge population and supply shortage at home.

So far, it has provided more than 350 million doses of COVID-19 vaccines to the international community, including vaccine assistance to more than 80 developing countries and exporting vaccines to more than 40 nations, which has made a significant contribution to the accessibility and affordability of vaccines.

On Tuesday, the CoronaVac COVID-19 vaccine, developed by Chinese pharmaceutical company Sinovac Biotech, was validated for emergency use by the World Health Organization (WHO).

The Sinovac vaccine is the second one from China to be included in the WHO Emergency Use Listing, following the Sinopharm vaccine, which was validated earlier last month.

The validation provides solid proof that the Chinese vaccines are both safe and efficacious, while further contributing to bridging the “immunization gap” generated by the inequity in vaccine distribution.

At the Global Health Summit in late May, China promised more practical action to combat the pandemic across the world.

The country reiterated its support for Chinese vaccine companies in transferring technologies to other developing countries and carrying out joint production with them.

China has also announced support for waiving intellectual property rights on COVID-19 vaccines, and it supports the World Trade Organization and other international institutions in making an early decision on this matter.

China has also proposed an international forum on vaccine cooperation to explore ways of promoting the fair and equitable distribution of vaccines around the world.

“With the production capacity of COVID-19 vaccines expected to increase in the second half of this year, Chinese vaccine enterprises and Chinese vaccines will definitely contribute more to the building of a global community of health for all,” Zheng said. Enditem

About Xinhua Silk Road

Xinhua Silk Road (en.imsilkroad.com) is the Belt and Road Initiative (BRI) portal. China’s silk road economic belt and the 21st century maritime silk road website, include BRI Policy, BRI Trade, BRI Investment, Belt and Road weekly, Know Belt and Road, and the integrated information services for the Belt and Road Initiative (BRI).

Source: China Focus: Over 700 mln COVID-19 vaccine doses administered across China

Labels:

Comments

Post a Comment

Popular posts from this blog

China’s Xiamen posts 1,000 China-Europe freight train trips

Abstract : Xiamen, a coastal city in east China's Fujian Province, Wednesday saw the 1,000th China-Europe freight train trip since the city launched the service in 2015. The X8098 train leaves Haicang station in Xiamen of east China’s Fujian Province for Hamburg, Germany, bringing the number of train trips of China-Europe freight train service to 1,000 on June 2, 2021. (Xinhua/Lin Shanchuan) XIAMEN, June 2 (Xinhua) — Xiamen, a coastal city in east China’s Fujian Province, Wednesday saw the 1,000th China-Europe freight train trip since the city launched the service in 2015. With 50 carriages loaded with daily necessities, auto parts and other goods, the X8098 train left the Haicang station of Xiamen for Germany Wednesday morning, bringing the number of train trips of such service to 1,000. Launched in August 2015, Xiamen’s rail cargo service to Europe and Central Asia has so far transported nearly 80,000 TEUs of goods worth more than 3 billion U.S. dollars, which...
Post a Comment
Read more

China drives global oil demand growth during pandemic

Abstract : China, with its rising refining industry, has driven global oil demand as the COVID-19 pandemic slashed it, and is emerging in the global refining industry shift, according to the International Energy Agency. Photo taken on July 21, 2020 shows the deck of the Kantan No.3 offshore oil platform in the northern waters of the South China Sea. (Xinhua/Pu Xiaoxu) China’s refiners are becoming a growing force in international markets for gasoline and diesel among other fuels, according to the International Energy Agency. NEW YORK, Nov. 26 (Xinhua) — China, with its rising refining industry, has driven global oil demand as the COVID-19 pandemic slashed it, and is emerging in the global refining industry shift, according to the International Energy Agency. Bloomberg quoted the agency as saying that as the demand for plastics and fuels grows in China and the rest of Asia, where economies are quickly rebounding from the pandemic, the refining capacity in China has been expanded....
Post a Comment
Read more

Singapore’s manufacturing output declines 0.9 pct on year in October

Abstract : Singapore Economic Development Board announced on Thursday that the country's manufacturing output decreased 0.9 percent year on year in October, compared to a revised 25.6 percent rise in September. SINGAPORE, Nov. 26 (Xinhua) — Singapore Economic Development Board announced on Thursday that the country’s manufacturing output decreased 0.9 percent year on year in October, compared to a revised 25.6 percent rise in September. Excluding biomedical manufacturing, the output fell 2.7 percent in October from a year ago. On a seasonally adjusted month-on-month basis, Singapore’s manufacturing output decreased 19 percent in October. Excluding biomedical manufacturing, the output fell 2.9 percent. As for the performance of different clusters, the electronics cluster’s output fell 0.6 percent year on year in October, compared to a revised 33.1 percent increase in September. The biomedical manufacturing cluster saw its output grow 10.2 percent in October, compared to a revi...
Post a Comment
Read more